Medifast Inc Stock Performance
| MED Stock | USD 33.42 0.82 2.52% |
The company secures a Beta (Market Risk) of 1.48, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MEDIFAST INC will likely underperform. MEDIFAST INC has an expected return of -0.68%. Please make sure to verify MEDIFAST INC skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if MEDIFAST INC performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MEDIFAST INC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in May 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 2.82 | Five Day Return 4.59 | Year To Date Return (52.27) | Ten Year Return 3.62 | All Time Return 509.45 |
Forward Dividend Yield 0.2035 | Payout Ratio 0.3622 | Forward Dividend Rate 6.6 | Dividend Date 2023-11-07 | Ex Dividend Date 2023-09-18 |
1 | Four Missing Bolts Confound Alaska Airlines 737-9 MAX Investigation | 02/07/2024 |
2 | Medifast, Inc.s 26 percent Dip In Price Shows Sentiment Is Matching Earnings | 02/22/2024 |
3 | Hey, Bottom Fishers 3 Beaten Up Stocks to Buy for Short-Term Gains | 03/07/2024 |
4 | Acquisition by Jonathan Mackenzie of 548 shares of MEDIFAST INC subject to Rule 16b-3 | 03/08/2024 |
5 | Acquisition by Daniel Chard of 45087 shares of MEDIFAST INC subject to Rule 16b-3 | 03/13/2024 |
6 | Disposition of 1859 shares by Daniel Chard of MEDIFAST INC at 36.61 subject to Rule 16b-3 | 03/15/2024 |
7 | Medifast Soars 5.9 percent Is Further Upside Left in the Stock | 03/18/2024 |
8 | Disposition of tradable shares by James Maloney of MEDIFAST INC at 36.61 subject to Rule 16b-3 | 03/19/2024 |
9 | MEDIFAST Down 11.5 percent Since Last Earnings Report Can It Rebound | 03/21/2024 |
10 | Acquisition by Daniel Chard of 34076 shares of MEDIFAST INC subject to Rule 16b-3 | 04/01/2024 |
11 | Personal Care Stocks Q4 Teardown Coty Vs The Rest - The Globe and Mail | 04/08/2024 |
12 | Acquisition by Constance Hallquist of tradable shares of MEDIFAST INC at 106.93 subject to Rule 16b-3 | 04/12/2024 |
13 | Q4 Earnings Highlights Este Lauder Vs The Rest Of The Personal Care Stocks | 04/18/2024 |
| Begin Period Cash Flow | 87.7 M |
MEDIFAST |
MEDIFAST INC Relative Risk vs. Return Landscape
If you would invest 5,342 in MEDIFAST INC on January 24, 2024 and sell it today you would lose (2,000) from holding MEDIFAST INC or give up 37.44% of portfolio value over 90 days. MEDIFAST INC is generating negative expected returns assuming volatility of 3.4618% on return distribution over 90 days investment horizon. In other words, 30% of stocks are less volatile than MEDIFAST, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MEDIFAST INC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDIFAST INC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MEDIFAST INC, and traders can use it to determine the average amount a MEDIFAST INC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1963
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MED |
Estimated Market Risk
| 3.46 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MEDIFAST INC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDIFAST INC by adding MEDIFAST INC to a well-diversified portfolio.
MEDIFAST INC Fundamentals Growth
MEDIFAST Stock prices reflect investors' perceptions of the future prospects and financial health of MEDIFAST INC, and MEDIFAST INC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDIFAST Stock performance.
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 221.73 M | ||||
| Shares Outstanding | 10.9 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.07 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 139.51 M | ||||
| Net Income | 99.42 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 22.01 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 18.69 X | ||||
| Cash Flow From Operations | 147.66 M | ||||
| Earnings Per Share | 9.10 X | ||||
| Market Capitalization | 355.2 M | ||||
| Total Asset | 309.91 M | ||||
| Retained Earnings | 174.65 M | ||||
| Working Capital | 131.73 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
About MEDIFAST INC Performance
To evaluate MEDIFAST INC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when MEDIFAST INC generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare MEDIFAST Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand MEDIFAST INC market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents MEDIFAST's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 67.27 | 63.91 | |
| Return On Tangible Assets | 0.32 | 0.34 | |
| Return On Capital Employed | 0.58 | 0.61 | |
| Return On Assets | 0.32 | 0.34 | |
| Return On Equity | 0.49 | 0.84 |
Things to note about MEDIFAST INC performance evaluation
Checking the ongoing alerts about MEDIFAST INC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEDIFAST INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEDIFAST INC generated a negative expected return over the last 90 days | |
| MEDIFAST INC has high historical volatility and very poor performance | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Q4 Earnings Highlights Este Lauder Vs The Rest Of The Personal Care Stocks |
- Analyzing MEDIFAST INC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEDIFAST INC's stock is overvalued or undervalued compared to its peers.
- Examining MEDIFAST INC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEDIFAST INC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEDIFAST INC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEDIFAST INC's stock. These opinions can provide insight into MEDIFAST INC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.